Navigation Links
Longer treatment benefits sleep apnea patients

WHAT: Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. This is the first study to identify the nightly duration of CPAP use needed to gain maximum benefit for daytime alertness and functioning.

Researchers at seven sleep centers in the United States and Canada studied 149 adults with sleep apnea to determine how long they routinely used CPAP each night. In addition, patients were evaluated for daytime symptoms such as excessive daytime sleepiness using two widely accepted assessment tools, and for daytime functioning using a standardized test before treatment and after three months of CPAP therapy. The findings suggest that most patients should use CPAP for at least 7.5 hours each night to realize the greatest possible benefits of therapy.

"Relationship Between Hours of CPAP Use and Achieving Normal Levels of Sleepiness and Daily Functioning," is published in the June issue of the journal SLEEP.

More than 12 million adult Americans are believed to have sleep apnea, a common disorder in which the upper airway is intermittently narrowed during sleep, causing breathing to be difficult or even completely blocked. The CPAP device is worn while the patient sleeps and works by blowing just enough air into the nose to keep the patient's throat open.

Because they often find the CPAP device cumbersome, many patients do not use it consistently or for long enough periods while sleeping. In the current study, for example, patients used CPAP on average about 5 hours a night. The researchers found that although daytime sleepiness could be improved after 4 hours to 6 hours a night, depending on the measurement used, functional status or quality-of-life improvements were maximized after 7.5 hours of use each night. Although individual patient response to CPAP therapy can vary, these latest findings provide a yardstick to help clinicians assess whether a patient's use is optimal.
'"/>

Source:NIH/National Heart, Lung and Blood Institute


Related biology news :

1. Longer-lived rodents have lower levels of thyroid hormone
2. Protein discovery could unlock the secret to better TB treatment
3. Topical treatment shown to inhibit HIV and herpes simplex virus infection
4. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
5. Researchers add new tool to tumor-treatment arsenal
6. Potential treatments for neurofibromatosis
7. Nanoparticles offer new hope for detection and treatment
8. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
9. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
10. New understanding of DNA repair may pave way to cancer treatments
11. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... 2016  NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a nanomedicine ... , MD, MPH, will present information about the company,s programs at ... New York City . --> ... Room at 5:30PM EST. Registered attendees can request a one on ... . --> New York City ...
(Date:2/8/2016)... February 8, 2016 ... or the "Company"), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, ... its Chlamydia trachomatis (CT) test to be launched on the ... Directive (98/79/EC), the CT test is now cleared for sale ... --> The launch of the io® CT test signals ...
(Date:2/5/2016)... ATCC, the premier global biological materials resource ... and life science researchers that are working to address ... CDC website . --> CDC ... a single-stranded RNA virus of the Flaviviridae family, genus ... Chikungunya Viruses. Zika virus is transmitted to humans primarily ...
(Date:2/5/2016)... FRANCISCO , February 5, 2016 ... a biotechnology company focused on developing products for ... has requested Rare Pediatric Disease Designation (RPDD) from the ... pigmentosa (RP) with MANF. MANF was previously granted orphan ... 2014. --> Amarantus BioScience Holdings, Inc. ...
Breaking Biology Technology: